ArticleRMD open2026
Behçet's syndrome epidemiology in England: a real-world retrospective cohort analysis with a nested case-control study using linked UK primary and secondary care data.
Article in RMD open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBehçet's syndrome (BS) is rare in the West. Using UK-linked primary and secondary care data we examine incidence, prevalence and clinical characteristics of this multisystem syndrome.
methodsClinical Practice Research Datalink (CPRD) Aurum and linked Hospital Episode Statistics (HES) enabled estimates of BS epidemiology using the earliest diagnosis code in CPRD or HES between 2001 and 2021. Median time from the first clinical code of a manifestation of interest to confirmed BS diagnosis was determined. A matched case-control design (CPRD Aurum) enabled ORs for BS for a variety of preselected covariates of interest to be calculated.
results1565 incident BS cases arose in the study interval, translating to a final incidence rate of 0.75/100 000 person years at risk in 2021. Prevalence rose from 8.62 to 19.80 per 100 000 person years. In 1628 cases of BS in CPRD Aurum, matched with 11 190 controls, the triad of genital ulceration (adjusted OR (aOR) 155.08), uveitis (aOR 43.00) and oral ulceration (aOR 24.73) was significantly increased among participants with BS. ORs for Crohn's disease (5.69) were also higher in the BS cohort compared with controls. First appearance of the clinical code for genital ulceration was associated with the shortest interval to diagnosis (median 240 days; IQR 63-745).
conclusionBS prevalence appears to increase over time in the UK, potentially linked to changing population demographics and migration, and to performance characteristics of the 2014 International Criteria for Behçet's Disease classification criteria in low-prevalence settings. Recognised clinical characteristics and inflammatory conditions with phenotypical overlap were associated with BS. Diagnostic delay could be reduced by recognition of risk factors and differentiating clinical manifestations. Case ascertainment relied on diagnostic coding without direct validation against classification criteria, which is an important limitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.